Article
Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
Author/s | Santos, Marta
Corma Gómez, Anaïs Martin Carmona, Jesica Perez Garcia, Margarita Martin Sierra, Carmen Rincón Mayo, Pilar González Serna, Alejandro Pineda, Juan Antonio Real, Luis Miguel Macias, Juan |
Department | Universidad de Sevilla. Departamento de Fisiología |
Publication Date | 2023-10-31 |
Deposit Date | 2024-04-04 |
Published in |
|
Abstract | Lockdown due to the coronavirus disease 2019 (COVID-19) pandemic led to increases in weight in part of the
population. Weight gain leads to hepatic steatosis (HS). Antiretroviral treatment could also influence HS in people ... Lockdown due to the coronavirus disease 2019 (COVID-19) pandemic led to increases in weight in part of the population. Weight gain leads to hepatic steatosis (HS). Antiretroviral treatment could also influence HS in people with human immunodeficiency virus (PWH). The impact of lockdown on HS in PWH is unknown. The aim of this study was to analyze the changes in HS, as measured by the controlled attenuation parameter (CAP), during the COVID-19 pandemic in PWH. |
Funding agencies | Instituto de Salud Carlos III Fondos Europeos FEDER |
Project ID. | PI018/00606 |
Citation | Santos, M., Corma Gómez, A., Martin Carmona, J., Perez Garcia, M., Martin Sierra, C., Rincón Mayo, P.,...,Macias, J. (2023). Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide. Open Forum Infectious Diseases, 10 (11), ofad532. https://doi.org/10.1093/ofid/ofad532. |
Files | Size | Format | View | Description |
---|---|---|---|---|
ofad532.pdf | 557.8Kb | [PDF] | View/ | |